US 6537969B1
· Blass
· 2003
[cited by applicant]
US 7982066B2
· Scheele
· 2011
[cited by applicant]
US 9597367B2
· Wolfe et al.
· 2017
[cited by applicant]
US 20030055099A1
· Martynyuk et al.
· 2003
[cited by applicant]
US 20130084378A1
· Jun et al.
· 2013
[cited by applicant]
US 20140243400A1
· Mcgill
· 2014
[cited by applicant]
US 20160038565A1
· Khan
· 2016
[cited by applicant]
CA 2972889A1
· 2016
[cited by applicant]
CN 105982914A
· 2016
[cited by applicant]
EP 2196203A1
· 2010
[cited by applicant]
EP 2676664A1
· 2013
[cited by applicant]
EP 2881112A1
· 2015
[cited by applicant]
GB 2029220A
· 1980
[cited by applicant]
JP H0873351A
· 1996
[cited by applicant]
JP 2007161642A
· 2007
[cited by applicant]
JP 6023813B2
· 2016
[cited by applicant]
WO 2001051047A1
· 2001
[cited by applicant]
WO 2003013487A2
· 2003
[cited by applicant]
WO 2005034932A2
· 2005
[cited by applicant]
WO 2006046746A1
· 2006
[cited by applicant]
WO 2007049818A1
· 2007
[cited by applicant]
WO 2012040707A2
· 2012
[cited by applicant]
WO 2012147901
· 2012
[cited by applicant]
WO 2016093104A1
· 2016
[cited by applicant]
WO 2016116580A1
· 2016
[cited by applicant]
WO 2016179657A1
· 2016
[cited by applicant]
WO 2016181335A1
· 2016
[cited by applicant]
WO 2017020121A1
· 2017
[cited by applicant]
WO 2017089612A1
· 2017
[cited by applicant]
WO 2018201024A1
· 2018
[cited by applicant]
WO 2019021135
· 2019
[cited by applicant]
WO 2019021137A1
· 2019
[cited by applicant]
WO 2019070750A1
· 2019
[cited by applicant]
WO 2019165321A1
· 2019
[cited by applicant]
WO 2020003013A1
· 2020
[cited by applicant]
WO 12022023932A1
· 2022
[cited by applicant]
WO 2022266480A1
· 2022
[cited by applicant]
Green et al. (Biochmica et Biophysica Acta 1588 (2002) 94-101 (Year: 2002).
[cited by examiner]
Balaraman Kalyanaraman, “Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?” Redox Biology, 29: 101394 (2020).
[cited by applicant]
Choudhury et.al., Mitochondrial determinants of cancer health disparities, Seminars in Cancer Biology, 2017, 47:125-146.
[cited by applicant]
International Search Report dated Mar. 16, 2021, for PCT/IB2020/062291, 5 pp.
[cited by applicant]
Written Opinion of the International Searching Authority dated Mar. 16, 2021, for PCT/IB2020/062291, 8 pp.
[cited by applicant]
Roberto Marques Damiani et al., “Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone”, Archives of Toxicology, vol. 90, No. 9, Jun. 25, 2016, pp. 2063-2076.
[cited by applicant]
Chowdhury S. Abdullah et al., “Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration”, Scientific Reports, vol. 9, No. 1, Feb. 14, 2019,…
[cited by applicant]
Anouk E. Hiensch et al., “Doxorubicin-induced skeletal muscle atrophy: Elucidating the underlying molecular pathways”, Acta Physiologica, vol. 229, No. 2, Oct. 10, 2019, 18 pp.
[cited by applicant]
Laura A.A. Gilliam et al., “The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle”, Free Radical Biology and Medicine, vol. 65, Sep. 7, 2013, pp. 988-996.
[cited by applicant]
Bianchi et al. “Not all cancers are created equal: Tissue specificity in cancer genes and pathways”, Current Opinion in Cell Biology. 2020; 63:135-143, Year: 2020.
[cited by applicant]
Boshuizen et al. “Rational Cancer Treatment Combinations: An Urgent Clinical Need”, Molecular Cell, 2020, 78:1002-1018, Year: 2020.
[cited by applicant]
Demarco, C. “Adenocarcinomas: 6 things to know about the ‘cancer of the cavities’”, MD Anderson Cancer Center, 2021, https://www.mdanderson.org/cancerwise/adenocarcinomas-6-things-to-know-about-the-cancer-of-the-cavitie…
[cited by applicant]
Fakouri et al. “From Powerhouse to Perpetrator-Mitochondria in Health and Disease”, Biology. 2019;8(2): 3, Year: 2019.
[cited by applicant]
Hörig et al. “From bench to clinic and back: Perspective on the IQPC Translational Research conference”, Journal of Translational Medicine 2004, 2(44), Year: 2004.
[cited by applicant]
MedlinePlus. Types of Chemotherapy. https://medlineplus.gov/ency/patientinstructions/000910.htm#:˜:text=There%20are%20more%20than%20100,from%20typical%20chemotherapy%20side%20effects) (Year: 2023).
[cited by applicant]
Schafer et al. “Failure is an option: learning from unsuccessful proof-of-concept trials”, Drug Discovery Today, 13 (21/22), 913-916, Year: 2008.
[cited by applicant]
Anonymous: “Amino acid-derived therapy for Inflammatory bowel disease: L-Leucine, the branched chain amino acid, promotes NFKB-p50/p65 dimer formation, induces inflammatory gene expression downstream of RelA/p65, inhibi…
[cited by applicant]
Ashida, Toshifumi et al., “Effect of Oral Administration of Isoleucine, Stimulant of Innate Immunity, in IBD Patients”, Gastroenterology, vol. 26, No. 4, Suppl 2, Apr. 1, 2004, 1 page, XP093023803, URL:https : //www.gas…
[cited by applicant]
Beale et al., A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease No Evidence of Benefit, JAMA Neurol., 71(5), pp. 543-552, 2014.
[cited by applicant]
Bonfili et al. The FEBS Journal. 2017; 284: 1726-1737 (Year: 2017).
[cited by applicant]
Bournat, J.C., et al., Mitochondrial Dysfunction in Obesity Current Opinion Endocrinol Obesity, October, 17(5): 446-452, 2010.
[cited by applicant]
Brocca et al., “Proteomic analysis of plasma after branched chain enriched mixture supplementation in mice”, Journal of the International Society of Sports Nutrition, vol. 10, No. 1, Apr. 3, 2013, 5 pages.
[cited by applicant]
Brown et al., Mitochondrial function as a therapeutic target in heart failure, Nat Rev Cardiol., 14(4), pp. 238-250, 2017.
[cited by applicant]
Daher et al., J Clin Transl Hepatol. Mar. 28, 2018;6(1 ):69-78 (Year: 2018).
[cited by applicant]
Unknown, Database WPI Week 200744, May 3, 2007, Thomson Scientific, London, GB, XP002788927, 3 pages.
[cited by applicant]
Chiechio, et al., “L-Acetylcarnitine: A Proposed Therapeutic Agent for Painful Peripheral Neuropathies”, Current Neuropharmacology, vol. 4, No. 3, Jul. 1, 2006, pp. 233-237 (5 pages).
[cited by applicant]
Fernández-Vizarra, et al., Tissue-specific differences in mitochondrial activity and biogenesis, Mitochondrion, vol. 11, pp. 207-213, 2011.
[cited by applicant]
Gorshinova et al., “Mitochondrial dysfunction as one of the mechanisms of impaired reproductive function in obesity.” Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2014; 7: 9-13. in Russian with English Abstract.
[cited by applicant]
Hall et al., “Lipid Peroxidation in Brain or Spinal Cord Mitochondria After Injury” J Bioenerg. Biomembr. Apr. 2016 ; 48(2): 169-174 (2017).
[cited by applicant]
Keenan et al,, Effects of carboxylic acids on the uptake of non-transferrin-bound iron by astrocytes, Neurochemistry International, 56: 843-849, 2010.
[cited by applicant]
Kim, Yun-Gi et al., “Neonatal acquisition of
[cited by applicant]
Liu, Yulan et al., “Roles of amino acids in preventing and treating intestinal diseases: recent studies with pig models”, Amino Acids, vol. 49, No. 8, Jun. 14, 2017, pp. 1277-1291.
[cited by applicant]
Ma et al., Inhibition of AMP-Activated Protein Kinase Signaling Alleviates Impairments in Hippocampal Synaptic Plasticity Induced by Amyloid, The Journal of Neuroscience, 34(36), 12230-12238, Sep. 3, 2014.
[cited by applicant]
Mao, Xiangbing et al, “I-Isoleucine Administration Alleviates DSS-Induced Colitis by Regulating TLR4/MyD88/NF-kB Pathway in Rats”, Frontiers in Immunology, vol. 12, Article 817583, Jan. 11, 2022, 12 pages.
[cited by applicant]
Unknown, MP Biomedical—Technical Information—AIN-93-Diet,pp. 1-3 (Year: 2023).
[cited by applicant]
Nakagaichi, M., et al., “Effects of Exercise Training Plus Vespa Amino Acid Mixture (VAAM) Ingestion in Obese Women,” Japanese Journal of Health Promotion, Mar. 11-16, 2001 with English Abstract.
[cited by applicant]
Nakamura, E., et al., “Assessment of Biological Age by Principal Component Analysis,” Mechanisms of Ageing and Development, vol. 46. Issues1-3, pp. 1-18, 1988, with English Translation of Office Action for JP Applicatio…
[cited by applicant]
Nergiz et al.; “Organic acid content and composition of the olive fruits during ripening and its relationship with oil and sugar”; 2009; Scientia Horticulturae; 122: 216-220 (Year: 2009).
[cited by applicant]
Pantucket al. Anesth Analg. 1989; 69: 727-731 (Year: 1989).
[cited by applicant]
Rao et al., Mitochondrial permeability transition pore is a potential drug target for neurodegeneration, Biochimica et Biophysica Acta, 1267-1272, 2014.
[cited by applicant]
Sbodio et al., Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities, Antioxidants & Redox Signaling, vol. 30, No. 11, pp. 1450-1499, 2019.
[cited by applicant]
Scholpa & Schnellmann, “Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target.” J Pharmacol Exp Ther 363:303-313, Dec. 2017.
[cited by applicant]
Short et al., Decline in skeletal muscle mitochondrial function with aging in humans, PNAS, vol. 102, No. 15, pp. 5618-5623, Apr. 12, 2005.
[cited by applicant]
Sprong et al., “Dietary cheese whey protein protects rats against mild dextran sulfate sodium-induced colitis: Role of mucin and microbiota”, Journal of Dairy Science, vol. 93, No. 4, Apr. 1, 2010, pp. 1364-1371.
[cited by applicant]
Sullivan et al., “Mitochondrial Permeability Transition in CNS Trauma: Cause or Effect of Neuronal Cell Death?” Journal of Neuroscience Research, 2005, 79:231-239.
[cited by applicant]
Sun et al., The Mitochondrial Basis of Aging, Mol Cell., 61(5), pp. 654-666, Mar. 3, 2016.
[cited by applicant]
Tapper et al., JAMA. 2023;329(18):1589-1602 (Year: 2023).
[cited by applicant]
Tedesco et al., A specific amino acid formula prevents alcoholic liver disease in rodents, Am J Physiol Gastrointest Liver Physiol ., Epub Jan. 25, 2018, 314(5):G566-G582.
[cited by applicant]
Vingtdeux et al., AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies, Acta Neuropathol, vol. 121, pp. 337-349, 2010.
[cited by applicant]
Wang et al., “Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure,” CNS Neurosci Ther. 25: 816-824 (2019).
[cited by applicant]
Wang, X. et al., “Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels” Molecular Oncology, Elsevier. Jul. 27, 2011., vol. 5, No. 5, pp. 399-409 (11 pages).
[cited by applicant]
Westermann et al., Mitochondrial fusion and fission in cell life and death, Molecular Cell Biology, vol. 11, 13 pages, Dec. 2010.
[cited by applicant]
Youle et al., Mitochondrial Fission, Fusion, and Stress, Science, 337(6098), pp. 1062-1065, Aug. 31, 2012.
[cited by applicant]